National Research Corp chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share 6.04
Dividend & Yield0.84$ (2.27%)
Beta 0.51
Market capitalization 913.57M
Operating cash flow 40.23M
ESG Scores unknown

Company description

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

Sector: Healthcare - Industry: Health Information Services

Financial Ratios
Quick Ratio1.82
Working Capital1.12
Return On Equity0.44
Debt To Equity0.26
Fixed Asset Ratio0.02
Fixed Interest Cover30.42

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities -491k 744k -1.02M 1.39M
Total Cashflows From Investing Activities -5.97M -4.66M -3.72M -8.51M
Net Borrowings 36.77M -3.94M -3.9M -4.59M
Total Cash From Financing Activities -54.5M -36.35M -15.5M -18.16M
Change To Operating Activities -1.51M -450k 208k -378k
Issuance Of Stock 1.73M 1.73M 1.73M 446k
Net Income 30.05M 32.41M 37.26M 37.47M
Change In Cash -21.74M 526k 21.17M 19.67M
Effect Of Exchange Rate -1.12M 611k -236k 3k
Total Cash From Operating Activities 39.85M 40.92M 40.64M 46.34M
Depreciation 5.46M 5.54M 6.79M 6.05M
Change To Account Receivables 2.77M 311k -2.27M 343k
Other Cashflows From Financing Activities -72.56M -36k -36k
Change To Netincome 2.89M 2.36M 1.2M 987k
Capital Expenditures -5.97M -4.66M -3.98M -5.51M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development
Income Before Tax 34.71M 40.52M 41.47M 48.62M
Net Income 30.05M 32.41M 37.26M 37.47M
Selling General Administrative 31.37M 32.97M 34.44M 38.84M
Gross Profit 72.11M 81.55M 84.09M 95.6M
Ebit 35.27M 43.03M 42.86M 50.71M
Operating Income 35.27M 43.03M 42.86M 50.71M
Interest Expense -1.51M -2.09M -1.81M -1.67M
Income Tax Expense 4.66M 8.11M 4.21M 11.15M
Total Revenue 119.69M 127.98M 133.28M 147.95M
Cost Of Revenue 47.58M 46.44M 49.19M 52.35M
Total Other Income ExpenseNet -566k -2.52M -1.39M -2.09M
Net Income From Continuing Ops 30.05M 32.41M 37.26M 37.47M
Net Income Applicable To Common Shares 29.95M 32.3M 37.2M 37.45M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 88.95M 77.79M 69.11M 72.2M
Total Stockholder Equity 19.08M 32.89M 64.31M 85.34M
Other Current Liabilities 33.99M 22.25M 15.93M 20.61M
Total Assets 108.03M 110.69M 133.42M 157.54M
Common Stock 30k 30k 31k 31k
Other Current Assets 171k 1.79M 1.31M 883k
Retained Earnings -106.34M -93.36M -61.38M -36.11M
Treasury Stock -31.92M -35.94M -46.13M -52.52M
Cash 12.99M 13.52M 34.69M 54.36M
Total Current Liabilities 47.11M 38.16M 31.68M 40.39M
Other Stockholder Equity -2.92M -2.21M -2.4M -2.38M
Property, Plant, and Equipment 14.15M 15.16M 13.03M 13.37M
Total Current Assets 28.41M 29.16M 54.11M 73.71M
Net Tangible Assets -40.85M -26.77M 5.65M 21.93M
Net Receivables 12.32M 11.81M 15.47M 14.58M
Accounts Payable 613k 1.28M 1.09M 1.94M


Insider Transactions

Here are the insider transactions of stock shares related to National Research Corp:

Filer Name Transaction Text Ownership Date Filer Relation Shares
AMANDLA MK TRUSTSale at price 40.54 per share.I2022-11-11Beneficial Owner of more than 10% of a Class of Security207
AMANDLA MK TRUSTSale at price 40.54 - 40.98 per share.I2022-11-01Beneficial Owner of more than 10% of a Class of Security62.39k
AMANDLA MK TRUSTSale at price 40.55 - 40.61 per share.I2022-10-27Beneficial Owner of more than 10% of a Class of Security36.72k
AMANDLA MK TRUSTSale at price 40.55 - 40.61 per share.I2022-10-24Beneficial Owner of more than 10% of a Class of Security24.44k
AMANDLA MK TRUSTSale at price 40.63 - 41.62 per share.I2022-10-19Beneficial Owner of more than 10% of a Class of Security32.88k
AMANDLA MK TRUSTSale at price 40.51 - 40.85 per share.I2022-10-14Beneficial Owner of more than 10% of a Class of Security43.78k
AMANDLA MK TRUSTSale at price 40.53 - 40.74 per share.I2022-10-04Beneficial Owner of more than 10% of a Class of Security43.21k
RAASCH JONA SConversion of Exercise of derivative security at price 13.17 per share.D2022-09-29Officer23.58k
AMANDLA MK TRUSTSale at price 38.59 per share.I2022-09-14Beneficial Owner of more than 10% of a Class of Security100k
AMANDLA MK TRUSTSale at price 36.00 per share.I2022-06-09Beneficial Owner of more than 10% of a Class of Security246.38k
AMANDLA MK TRUSTSale at price 39.87 per share.I2022-04-21Beneficial Owner of more than 10% of a Class of Security100
AMANDLA MK TRUSTSale at price 39.90 - 39.92 per share.I2022-04-20Beneficial Owner of more than 10% of a Class of Security3.52k
AMANDLA MK TRUSTSale at price 40.02 - 40.48 per share.I2022-04-08Beneficial Owner of more than 10% of a Class of Security2.4k
AMANDLA MK TRUSTSale at price 40.71 per share.I2022-04-06Trustee8.14k
AMANDLA MK TRUSTSale at price 40.15 - 40.39 per share.I2022-04-05Beneficial Owner of more than 10% of a Class of Security8.13k
HAYS MICHAEL DStock Gift at price 0.00 per share.D/I2021-12-29Chief Executive Officer36.5k
AMANDLA MK TRUSTSale at price 42.50 - 42.76 per share.I2021-12-28Beneficial Owner of more than 10% of a Class of Security5.05k
HRDY HELENConversion of Exercise of derivative security at price 13.17 per share.D2021-12-28Officer13.52k
HAYS MICHAEL DConversion of Exercise of derivative security at price 10.75 per share.D2021-12-22Chief Executive Officer14.95k
AMANDLA MK TRUSTSale at price 42.57 per share.I2021-12-17Beneficial Owner of more than 10% of a Class of Security5.84k
AMANDLA MK TRUSTSale at price 42.60 - 42.66 per share.I2021-12-13Trustee63.57k
AMANDLA MK TRUSTSale at price 43.33 per share.I2021-12-07Beneficial Owner of more than 10% of a Class of Security8.64k
AMANDLA MK TRUSTSale at price 42.44 - 43.01 per share.I2021-12-06Beneficial Owner of more than 10% of a Class of Security129.97k
AMANDLA MK TRUSTSale at price 49.00 per share.I2021-11-05Beneficial Owner of more than 10% of a Class of Security100
AMANDLA MK TRUSTSale at price 50.06 per share.I2021-11-03Beneficial Owner of more than 10% of a Class of Security50k
AMANDLA MK TRUSTSale at price 54.03 - 54.16 per share.I2021-09-02Beneficial Owner of more than 10% of a Class of Security16.15k
AMANDLA MK TRUSTSale at price 54.00 - 54.15 per share.I2021-08-31Beneficial Owner of more than 10% of a Class of Security3.85k
KARAS KEVIN RSale at price 53.16 per share.D2021-08-09Chief Financial Officer5k
HAYS MICHAEL DStock Gift at price 0.00 per share.I2021-07-12Chief Executive Officer10.5k
AMANDLA MK TRUSTSale at price 49.98 - 50.01 per share.I2021-05-25Beneficial Owner of more than 10% of a Class of Security16.29k
AMANDLA MK TRUSTSale at price 50.96 per share.I2021-05-21Beneficial Owner of more than 10% of a Class of Security11.33k
AMANDLA MK TRUSTSale at price 51.14 per share.I2021-05-04Beneficial Owner of more than 10% of a Class of Security1.23k
AMANDLA MK TRUSTSale at price 51.07 - 51.95 per share.I2021-05-03Beneficial Owner of more than 10% of a Class of Security16.29k
AMANDLA MK TRUSTSale at price 49.36 - 50.38 per share.I2021-04-29Beneficial Owner of more than 10% of a Class of Security80.7k
KARAS KEVIN RConversion of Exercise of derivative security at price 13.17 - 18.80 per share.D2021-03-23Chief Financial Officer24.65k
K I E TRUSTSale at price 51.00 per share.D2021-03-11Trustee4.75M
AMANDLA MK TRUSTSale at price 54.06 - 54.18 per share.I2021-03-03Trustee58.27k
MARTIN JOANN MSale at price 50.66 per share.D2021-02-12Director5k
MARTIN JOANN MStock Gift at price 0.00 per share.D2021-01-08Director28k
HAYS MICHAEL DConversion of Exercise of derivative security at price 9.14 per share.D2021-01-04Chief Executive Officer17.75k
HAYS MICHAEL DConversion of Exercise of derivative security at price 9.14 per share.D2021-01-04Chief Executive Officer17.75k
MARTIN JOANN MStock Gift at price 0.00 per share.D2020-12-29Director139.91k
HAYS MICHAEL DStock Gift at price 0.00 per share.D2020-12-16Chief Executive Officer21k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to National Research Corp. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on National Research Corp

Here is the result of two systematic investment strategies applied to National Research Corp. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on National Research Corp

The following chart shows the equity curve of the two systematic investment strategies applied to National Research Corp:

National Research Corp automated entries

The systematic investment strategy that buys the first day of the month would give a performance of -6.24% on the backtest period.

Performance at glance

Performance

-6.24 %

Latent gain

-141.27 $

Invested capital

2263.79 $

Annualized return

-1.51 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on National Research Corp

This is the result of two momentum investment strategies applied to National Research Corp. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on National Research Corp

The following chart shows all the entries opened by the momentum investment system on National Research Corp:

National Research Corp momentum entries
  • The first momentum investment strategy would give 2.83% of return on National Research Corp. That represents 169.13$ of latent gain with 5972.63$ of employed capital.
  • The second momentum investment strategy would give 6.77% of return on National Research Corp. That represents 237.79$ of latent gain with 3510.49$ of employed capital.
Performance at glance (1Q Momentum)

Performance

2.83 %

Latent gain

169.13 $

Invested capital

5972.63 $

Annualized return

2.64 %
Performance at glance (2Q Momentum)

Performance

6.77 %

Latent gain

237.79 $

Invested capital

3510.49 $

Annualized return

1.85 %

Momentum equity curve on National Research Corp

The following chart shows the equity curve of the two momentum strategies applied to National Research Corp:

National Research Corp momentum equity

Note: the dividends potentially given by National Research Corp are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on National Research Corp

The following chart shows the employed capital evolution of the two momentum strategies on National Research Corp since the beginning:

National Research Corp

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on National Research Corp

Buy the dip entry openings on National Research Corp

National Research Corp

The performance achieved by the robo-advisor on National Research Corp is 5.64%. That represents 14.46$ of latent gain with 256.5$ of employed capital. The following chart shows National Research Corp stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of National Research Corp, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

5.64 %

Latent gain

14.46 $

Invested capital

256.5 $

Annualized return

2.64 %

Equity curve of the strategy applied to National Research Corp

The following chart shows the result of the investment strategy applied to National Research Corp:

National Research Corp

Note: the dividends potentially given by National Research Corp are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on National Research Corp

The following chart shows the employed capital evolution since the beginning of the investment strategy on National Research Corp:

National Research Corp

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on National Research Corp

In this section, I will compare the three previous investment strategies applied to National Research Corp.

Equity curve comparison on National Research Corp

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

National Research Corp investment strategy comparison

Employed capital comparison on National Research Corp

National Research Corp investment comparison

Performance comparison on National Research Corp

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment -6.24% -141.27$ 2263.79$ -1.51%
Momentum 1 quarter 2.83% 169.13$ 5972.63$ 0.73%
Momentum 2 quarters 6.77% 237.79$ 3510.49$ 1.85%
Non-directional 5.64% 14.46$ 256.5$ 2.64%
Annualized return comparison

Automatic investment

-1.51 %

Momentum 1Q

1.85 %

Momentum 2Q

1.85 %

Non-directional

2.64 %

Correlated stocks

Here are the most positively and negatively correlated stocks with National Research Corp:

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months


Note: The algorithm computes the probability of correlation between National Research Corp and the other stocks. There may be false positives or some missing correlated stocks. If the price of National Research Corp does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name National Research Corp
Country United States
City Lincoln
Address 1245 Q Street
Phone 402 475 2525
Website nrchealth.com
FullTime employees 511
Industry Health Information Services
Sector Healthcare
Exchange XNAS
Ticker NRC
Market www.nasdaq.com

National Research Corp ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown